HHS unleashed in string of last-minute policies
Presented by CVS Health
On Tap
with FDA officials bracing for more. FDA shakeup in the final Trump days as officials depart amid the pandemic. Biden tees up vaccine plan this week after questions about hitting ambitious distribution goals.
It’s Tuesday, welcome back to Prescription Pulse. Another advocate for FDA as an independent agency? Commissioner Stephen Hahn says it s a timely question. As always, send tips to Sarah Owermohle at [email protected] or @owermohle. Loop in David Lim ([email protected] or @davidalim) and Brianna Ehley ([email protected] or @briannaehley).
Eye on FDA
FDA backtracks on hand-sanitizer fees
americanthinker.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanthinker.com Daily Mail and Mail on Sunday newspapers.
For their patriotic efforts, this is how these companies were thanked: the U.S. Food and Drug Administration (FDA) released new regulations and fees for organizations
As the fear of coronavirus swept the world, panic buying went into full swing. Suddenly, toilet paper and hand sanitizer became hot commodities that were difficult to find. The high demand for these products, and limited workforce availability because of the virus, resulted in severe shortages as companies were unable to meet the increased demand.
Fortunately, the United States is home to thousands of breweries and distilleries that had the ability to turn alcohol originally meant for consumption into a usable denatured hand sanitizer. When demand for hand sanitizer skyrocketed, several distilleries stepped up to the plate and implemented novel processes to mass produce the much-needed sanitizer. Virtually overnight, these companies produced, packaged, and delivered thousands of bottles of hand sanitizer to the Americ
Dive Brief:
The Trump administration on Friday finalized a rule requiring HHS to review existing regulations, with some exceptions, every 10 years based on their real-world impact.
If not reviewed and approved in time, old rules would automatically expire. When proposed in November, the rule sparked concern among providers and other groups concerned it would inject more regulatory uncertainty into the industry, and heap additional administrative burden onto HHS. The incoming Biden administration could look to overturn the rule.
The final version of the rule gives HHS more leniency in its initial review timeline. The government first determines whether a rule has a significant economic impact on small businesses and, if it does, make any changes or withdrawals within five years, instead of the initially proposed two.
HHS finalizes plan to review and eliminate old regulations
Modern Healthcare
Print
HHS on Friday finalized a rule requiring the department to review all of its regulations every 10 years to determine if they re still making the desired impact. Any rule that is not assessed will expire.
Additionally, the Trump administration said current rules older than a decade must be checked in the next five years, an extension from a two-year deadline in the proposed rule.
The review process won t apply to food and drug regulations or payment rules, according to the agency. Every one of our regulations is effectively a law, HHS Chief of Staff Brian Harrison said on a press call Friday. It was passed by no House, passed by no Senate and signed by no president.
vimarsana © 2020. All Rights Reserved.